查詢結果分析
相關文獻
- Potential of Circulating Immune Cells as Biomarkers of Nivolumab Treatment Efficacy for Advanced Hepatocellular Carcinoma
- 肝癌之非外科治療
- 乳癌的藥物治療
- 前導性Nivolumab合併化療改善可切除性肺癌無事件存活期
- 癌症負擔研究、
- 晚期肺癌病人接受首次免疫療法前衰弱狀況之初探
- Potential of Novel Colchicine Dosage Schedule for the Palliative Treatment of Advanced Hepatocellular Carcinoma
- Promotion of Prolactin in Non-small Cell Lung Cancer
- Potential of Novel Colchicine Dosage Schedule for the Palliative Treatment of Advanced Hepatocellular Carcinoma
- A History of Antidementic Drug Development in Japan
頁籤選單縮合
題 名 | Potential of Circulating Immune Cells as Biomarkers of Nivolumab Treatment Efficacy for Advanced Hepatocellular Carcinoma |
---|---|
作 者 | Hung, Yi-ping; Shao, Yu-yun; Lee, Jan-mou; Hsu, Chiun; Hsu, Chih-hung; Yang, Muh-hwa; Chao, Yee; | 書刊名 | Journal of the Chinese Medical Association |
卷 期 | 84:2 2021.02[民110.02] |
頁 次 | 頁144-150 |
分類號 | 418.31 |
關鍵詞 | Flow cytometry; Hepatocellular carcinoma; Immunotherapy; Nivolumab; Predictive markers; |
語 文 | 英文(English) |